{
  "resourceType" : "ValueSet",
  "id" : "type-of-blinding-ncit",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Placeholder</div>"
  },
  "url" : "https://www.vision-zero-oncology.de/fhir/ValueSet/type-of-blinding-ncit",
  "version" : "0.1.0",
  "name" : "VS_TypeOfBlinding_NCIT",
  "title" : "ValueSet Type of Blinding NCIt",
  "status" : "draft",
  "experimental" : false,
  "date" : "2023-09-27T08:44:59+00:00",
  "publisher" : "Berlin Institute of Health at Charité (BIH)",
  "contact" : [{
    "name" : "Berlin Institute of Health at Charité (BIH)",
    "telecom" : [{
      "system" : "url",
      "value" : "https://www.bihealth.org/"
    }]
  }],
  "description" : "Type of Blinding aus NCI Thesaurus (NCIt)",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "DEU"
    }]
  }],
  "copyright" : "NCI THESAURUS is a registered trademark of the National Cancer Institute.",
  "compose" : {
    "include" : [{
      "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
      "concept" : [{
        "code" : "C49659",
        "display" : "Open Label Study"
      },
      {
        "code" : "C28233",
        "display" : "Single Blind Study"
      },
      {
        "code" : "C15228",
        "display" : "Double Blind Study"
      },
      {
        "code" : "C66959",
        "display" : "Triple Blind Study"
      },
      {
        "code" : "C156592",
        "display" : "Open Label for Treatment And Double Blind to Dose"
      }]
    }]
  }
}